USA - NASDAQ:TELA - US8723811084 - Common Stock
ChartMill assigns a Buy % Consensus number of 82% to TELA. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-03-21 | Citizens Capital Markets | Maintains | Market Outperform -> Market Outperform |
| 2025-03-21 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-03-21 | Piper Sandler | Downgrade | Overweight -> Neutral |
| 2024-11-08 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2024-10-04 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2024-08-13 | Lake Street | Maintains | Buy -> Buy |
| 2024-08-13 | JMP Securities | Maintains | Market Outperform -> Market Outperform |
| 2024-08-13 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2024-08-13 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2024-07-25 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2024-05-10 | Piper Sandler | Reiterate | Overweight -> Overweight |
| 2024-03-22 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2024-03-22 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2023-12-27 | Lake Street | Reiterate | Buy -> Buy |
| 2023-11-10 | JMP Securities | Maintains | Market Outperform -> Market Outperform |
| 2023-03-28 | Canaccord Genuity | Reiterate | Buy |
| 2023-03-22 | JMP Securities | Reiterate | Market Outperform |
| 2022-11-10 | JMP Securities | Maintains | Market Outperform |
| 2022-11-10 | Piper Sandler | Maintains | Overweight |
11 analysts have analysed TELA and the average price target is 5.51 USD. This implies a price increase of 272.16% is expected in the next year compared to the current price of 1.48.
The consensus rating for TELA BIO INC (TELA) is 81.8182 / 100 . This indicates that analysts generally have a positive outlook on the stock.
The number of analysts covering TELA BIO INC (TELA) is 11.